JP Morgan Maintains Overweight on Erasca, Raises Price Target to $25

Benzinga Newsdesk www.benzinga.com Positive 68.6%

Neg 0% Neu 0% Pos 68.6%

JP Morgan analyst Anupam Rama maintains Erasca (NASDAQ:ERAS) with a Overweight and raises the price target from $24 to $25.